These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38064015)

  • 1. What does better look like in individuals with severe neurodevelopmental impairments? A qualitative descriptive study on SCN2A-related developmental and epileptic encephalopathy.
    Downs J; Ludwig NN; Wojnaroski M; Keeley J; Schust Myers L; Chapman CAT; Hecker J; Conecker G; Berg AT
    Qual Life Res; 2024 Feb; 33(2):519-528. PubMed ID: 38064015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-advocate-led global coalition adapting fit-for-purpose outcomes measures to assure meaningful inclusion of DEEs in clinical trials.
    Hecker J; Conecker G; Chapman C; Hommer R; Ludwig NN; Sevinc G; Te S; Wojnaroski M; Downs J; Berg AT
    Ther Adv Rare Dis; 2024; 18():26330040241249762. PubMed ID: 38911512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCN2A-Developmental and Epileptic Encephalopathies: Challenges to trial-readiness for non-seizure outcomes.
    Berg AT; Palac H; Wilkening G; Zelko F; Schust Meyer L
    Epilepsia; 2021 Jan; 62(1):258-268. PubMed ID: 33236786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phenotype and treatment of SCN2A-related developmental and epileptic encephalopathy.
    Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
    Epileptic Disord; 2020 Oct; 22(5):563-570. PubMed ID: 33000761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Developmental and Epileptic Encephalopathy and of Intellectual Disability and Epilepsy in Children.
    Poke G; Stanley J; Scheffer IE; Sadleir LG
    Neurology; 2023 Mar; 100(13):e1363-e1375. PubMed ID: 36581463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare diseases - rare outcomes: Assessing communication abilities for the developmental and epileptic encephalopathies.
    Berg AT; Kaat AJ; Zelko F; Wilkening G
    Epilepsy Behav; 2022 Mar; 128():108586. PubMed ID: 35158285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological features: The next precise step for SCN2A developmental epileptic encephalopathy.
    Miao P; Tang S; Ye J; Wang J; Lou Y; Zhang B; Xu X; Chen X; Li Y; Feng J
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1250. PubMed ID: 32400968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological concepts in human sodium channel epilepsies and their relevance in clinical practice.
    Brunklaus A; Du J; Steckler F; Ghanty II; Johannesen KM; Fenger CD; Schorge S; Baez-Nieto D; Wang HR; Allen A; Pan JQ; Lerche H; Heyne H; Symonds JD; Zuberi SM; Sanders S; Sheidley BR; Craiu D; Olson HE; Weckhuysen S; DeJonge P; Helbig I; Van Esch H; Busa T; Milh M; Isidor B; Depienne C; Poduri A; Campbell AJ; Dimidschstein J; Møller RS; Lal D
    Epilepsia; 2020 Mar; 61(3):387-399. PubMed ID: 32090326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of developmental and epileptic encephalopathies on caregivers: A literature review.
    Gallop K; Lloyd AJ; Olt J; Marshall J
    Epilepsy Behav; 2021 Oct; 124():108324. PubMed ID: 34607217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intervention to improve the quality of life in children of parents with serious mental illness: the Young SMILES feasibility RCT.
    Abel KM; Bee P; Gega L; Gellatly J; Kolade A; Hunter D; Callender C; Carter LA; Meacock R; Bower P; Stanley N; Calam R; Wolpert M; Stewart P; Emsley R; Holt K; Linklater H; Douglas S; Stokes-Crossley B; Green J
    Health Technol Assess; 2020 Nov; 24(59):1-136. PubMed ID: 33196410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes.
    Begemann A; Acuña MA; Zweier M; Vincent M; Steindl K; Bachmann-Gagescu R; Hackenberg A; Abela L; Plecko B; Kroell-Seger J; Baumer A; Yamakawa K; Inoue Y; Asadollahi R; Sticht H; Zeilhofer HU; Rauch A
    Mol Med; 2019 Feb; 25(1):6. PubMed ID: 30813884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic implication of a novel SCN2A mutation associated early-onset epileptic encephalopathy with Rett-like features.
    Liang JS; Lin LJ; Yang MT; Wang JS; Lu JF
    Brain Dev; 2017 Nov; 39(10):877-881. PubMed ID: 28709814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenotype study of SCN2A gene related epilepsy].
    Zeng Q; Zhang YH; Yang XL; Zhang J; Liu AJ; Liu XY; Jiang YW; Wu XR
    Zhonghua Er Ke Za Zhi; 2018 Jul; 56(7):518-523. PubMed ID: 29996185
    [No Abstract]   [Full Text] [Related]  

  • 15. The phenotypic spectrum of SCN2A-related epilepsy.
    Reynolds C; King MD; Gorman KM
    Eur J Paediatr Neurol; 2020 Jan; 24():117-122. PubMed ID: 31924505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and Genotypic Spectrum of Early-Onset Developmental and Epileptic Encephalopathies-Data from a Romanian Cohort.
    Riza AL; Streață I; Roza E; Budișteanu M; Iliescu C; Burloiu C; Dobrescu MA; Dorobanțu S; Dragoș A; Grigorescu A; Tătaru T; Ioana M; Teleanu R
    Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental and epileptic encephalopathy: Personal utility of a genetic diagnosis for families.
    Jeffrey JS; Leathem J; King C; Mefford HC; Ross K; Sadleir LG
    Epilepsia Open; 2021 Mar; 6(1):149-159. PubMed ID: 33681658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of developmental and epileptic encephalopathies on families: a qualitative study.
    Velarde-García JF; Güeita-Rodríguez J; Jiménez-Antona C; García-Bravo C; Aledo-Serrano Á; Gómez-Sánchez SM; Palacios-Ceña D
    Eur J Pediatr; 2024 Sep; 183(9):4103-4110. PubMed ID: 38965081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond.
    Wolff M; Brunklaus A; Zuberi SM
    Epilepsia; 2019 Dec; 60 Suppl 3():S59-S67. PubMed ID: 31904126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.